Skip to main content
. Author manuscript; available in PMC: 2015 May 28.
Published in final edited form as: Public Health Genomics. 2014 Feb 19;17(2):68–75. doi: 10.1159/000356708

Fig. 2.

Fig. 2

Interpretation of lung cancer risk conferred by GSTM1 to participant compared to others on 5-point scale. The majority of participants interpreted `GSTM1 present' to mean that risk of developing lung cancer is `slightly lower than average'. The majority of participants interpreted `GSTM1 missing' to mean that risk of developing lung cancer is `slightly higher than average'.